onureg
bristol-myers squibb pharma eeig - atsakitidiini - leukemia, myeloidi, akuutti - antineoplastiset aineet - onureg is indicated as maintenance therapy in adult patients with acute myeloid leukaemia (aml) who achieved complete remission (cr) or complete remission with incomplete blood count recovery (cri) following induction therapy with or without consolidation treatment and who are not candidates for, including those who choose not to proceed to, hematopoietic stem cell transplantation (hsct).
abecma
bristol-myers squibb pharma eeig - idecabtagene vicleucel - multiple myeloma; neoplasms; cancer; neoplasms, plasma cell; hemostatic disorders; vascular diseases; cardiovascular diseases; paraproteinemias; blood protein disorders; hematologic diseases; hemic and lymphatic diseases; hemorrhagic disorders; infectious mononucleosis; lymphoproliferative disorders; immunoproliferative disorders; immune system diseases - antineoplastiset aineet - abecma is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti cd38 antibody and have demonstrated disease progression on the last therapy.
breyanzi
bristol-myers squibb pharma eeig - cd19-directed genetically modified autologous cell-based product consisting of purified cd8+ t-cells (cd8+ cells), cd19-directed genetically modified autologous cell-based product consisting of purified cd4+ t cells (cd4+ cells) - lymphoma, large b-cell, diffuse; lymphoma, follicular; mediastinal neoplasms - antineoplastiset aineet - breyanzi is indicated for the treatment of adult patients with diffuse large b-cell lymphoma (dlbcl), high grade b-cell lymphoma (hgbcl), primary mediastinal large b-cell lymphoma (pmbcl) and follicular lymphoma grade 3b (fl3b), who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy.
sitavig 50 mg bukkaalitabletti, kiinnittyvä
vectans pharma - aciclovir - bukkaalitabletti, kiinnittyvä - 50 mg - asikloviiri
nyvigan voide + emätinpuikko, tabletti
dr. pfleger arzneimittel gmbh - nystatin - voide + emätinpuikko, tabletti - nystatiini
gastrogard 370 mg/g oraalipasta
boehringer ingelheim animal health nordics a/s - omeprazole - oraalipasta - 370 mg/g - omepratsoli
barbivet vet 30 mg tabletti
vetoquinol s.a. - phenobarbital - tabletti - 30 mg - fenobarbitaali
barbivet vet 60 mg tabletti
vetoquinol s.a. - phenobarbital - tabletti - 60 mg - fenobarbitaali
cefenil vet 50 mg/ml injektioneste, suspensio
norbrook laboratories (ireland) limited - ceftiofurum hydrochloridum - injektioneste, suspensio - 50 mg/ml
soluprick sq huonepölypunkit liuos ihopistotestiin
alk-abello a/s - dermatophagoides farinae, dermatophagoides pteronyssinus - liuos ihopistotestiin - allergiatestit